Home » Topics » Regulatory » EMA

EMA
RSS

Intravenous posaconazole recommended for approval in E.U.

Aug. 1, 2014

EMA accepts Eisai's request for accelerated assessment of lenvatinib

Aug. 1, 2014

EMA committee recommends approval of Baraclude for pediatric patients with HBV

July 30, 2014

Novo Nordisk receives positive CHMP opinion on Xultophy

July 29, 2014

CHMP recommends extension of Ozurdex indication in diabetic macular edema

July 28, 2014

EMA committee recommends approval of Zydelig in CLL and follicular lymphoma

July 28, 2014

CHMP adopts positive opinion for Imbruvica in CLL and MCL

July 28, 2014

First vaccine candidate for malaria accepted for E.U. regulatory review

July 25, 2014

EMA accepts MAA for asfotase alfa as a treatment for hypophosphatasia

July 25, 2014

Sunesis Pharmaceuticals receives positive opinion on pediatric investigation plan for vosaroxin

July 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...